Eur Respir J 1997; 10: 1496-1499
Copyright © ERS Journals Ltd 1997
Distribution of inhaled fluticasone propionate between human lung tissue and serum in vivo
N Esmailpour,
P Hogger,
KF Rabe,
U Heitmann,
M Nakashima,
and
P Rohdewald
High retention of inhaled glucocorticoids in the airways means prolonged anti-inflammatory action and low delivery into the serum. The objective of this study was to investigate the retention in and distribution of inhaled fluticasone propionate (FP) between central and peripheral human lung tissue and serum in vivo. In 17 patients undergoing lung resection surgery, a single 1.0 mg dose of FP was inhaled at varying time-points (range 2.8-21.7 h) preoperatively. Peripheral and central lung tissue was obtained, and blood was drawn simultaneously. FP concentrations in central lung tissue were approximately three to four times higher than peripheral lung tissue concentrations, which in turn, exceeded those found in serum by 10 times. FP was detectable up to 21 and 16 h, respectively, after inhalation, with drug levels falling almost in parallel in peripheral lung tissue and in serum. The results of this study demonstrate that fluticasone propionate is retained in lung tissue for a long time. Serum concentrations after a single inhaled dose are low. Retention of high concentrations of fluticasone propionate in the airways may promote high topical anti-inflammatory activity.
This article has been cited by other articles:

|
 |

|
 |
 
E. S. Mendes, G. Horvath, P. Rebolledo, M. E. Monzon, S. M. Casalino-Matsuda, and A. Wanner
Effect of an inhaled glucocorticoid on endothelial function in healthy smokers
J Appl Physiol,
July 1, 2008;
105(1):
54 - 57.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Derendorf
Pharmacokinetic and Pharmacodynamic Properties of Inhaled Ciclesonide
J. Clin. Pharmacol.,
June 1, 2007;
47(6):
782 - 789.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Dorscheid, B. J. Patchell, O. Estrada, B. Marroquin, R. Tse, and S. R. White
Effects of corticosteroid-induced apoptosis on airway epithelial wound closure in vitro
Am J Physiol Lung Cell Mol Physiol,
October 1, 2006;
291(4):
L794 - L801.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Fouty, T. Moss, V. Solodushko, and M. Kraft
Dexamethasone can stimulate G1-S phase transition in human airway fibroblasts in asthma
Eur. Respir. J.,
June 1, 2006;
27(6):
1160 - 1167.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Edwards, M. W. Johnson, and S. L. Johnston
Combination Therapy: Synergistic Suppression of Virus-Induced Chemokines in Airway Epithelial Cells
Am. J. Respir. Cell Mol. Biol.,
May 1, 2006;
34(5):
616 - 624.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Dijkstra, J M Vonk, H Jongepier, G H Koppelman, J P Schouten, N H T ten Hacken, W Timens, and D S Postma
Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex
Thorax,
February 1, 2006;
61(2):
105 - 110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Todorova, E. Gurcan, A. Miller-Larsson, and G. Westergren-Thorsson
Lung Fibroblast Proteoglycan Production Induced by Serum Is Inhibited by Budesonide and Formoterol
Am. J. Respir. Cell Mol. Biol.,
January 1, 2006;
34(1):
92 - 100.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Biggadike, I. Uings, and S. N. Farrow
Designing Corticosteroid Drugs for Pulmonary Selectivity
Proceedings of the ATS,
December 1, 2004;
1(4):
352 - 355.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Horvath, Z. Sutto, A. Torbati, G. E. Conner, M. Salathe, and A. Wanner
Norepinephrine transport by the extraneuronal monoamine transporter in human bronchial arterial smooth muscle cells
Am J Physiol Lung Cell Mol Physiol,
October 1, 2003;
285(4):
L829 - L837.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Escotte, O. Tabary, D. Dusser, C. Majer-Teboul, E. Puchelle, and J. Jacquot
Fluticasone reduces IL-6 and IL-8 production of cystic fibrosis bronchial epithelial cells via IKK-{beta} kinase pathway
Eur. Respir. J.,
April 1, 2003;
21(4):
574 - 581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Tulic and Q. Hamid
Contribution of the Distal Lung to the Pathologic and Physiologic Changes in Asthma: Potential Therapeutic Target Roger S. Mitchell Lecture
Chest,
March 1, 2003;
123
(2009):
348S - 355S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Carayol, I. Vachier, P. Chanez, A. M. Vignola, G. Chiappara, D. R. Dorscheid, and S. R. White
Corticosteroid-induced epithelial shedding in asthma
Am. J. Respir. Crit. Care Med.,
November 1, 2002;
166(9):
1290 - 1291.
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Miller-Larsson, A. R&D, O. Selroos, D. R. Dorscheid, and S. R. White
No Evidence of Glucocorticosteroid-induced Apoptosis of Airway Epithelial Cells In Vivo
Am. J. Respir. Crit. Care Med.,
June 1, 2002;
165(11):
1567 - 1568.
[Full Text]
|
 |
|

|
 |

|
 |
 
D. R. DORSCHEID, K. R. WOJCIK, S. SUN, B. MARROQUIN, and S. R. WHITE
Apoptosis of Airway Epithelial Cells Induced by Corticosteroids
Am. J. Respir. Crit. Care Med.,
November 15, 2001;
164(10):
1939 - 1947.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. MILLER-LARSSON, P. JANSSON, A. RUNSTROM, and R. BRATTSAND
Prolonged Airway Activity and Improved Selectivity of Budesonide Possibly Due to Esterification
Am. J. Respir. Crit. Care Med.,
October 1, 2000;
162(4):
1455 - 1461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. ZuWallack, J. Adelglass, D. P. Clifford, S. P. Duke, P. D. Wire, M. Faris, and S. M. Harding
Long-term Efficacy and Safety of Fluticasone Propionate Powder Administered Once or Twice Daily via Inhaler to Patients With Moderate Asthma
Chest,
August 1, 2000;
118(2):
303 - 312.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. JAFFUEL, P. DEMOLY, C. GOUGAT, P. BALAGUER, G. MAUTINO, P. GODARD, J. BOUSQUET, and M. MATHIEU
Transcriptional Potencies of Inhaled Glucocorticoids
Am. J. Respir. Crit. Care Med.,
July 1, 2000;
162(1):
57 - 63.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R J Meijer, H A M Kerstjens, L R Arends, H F Kauffman, G H Koëter, and D S Postma
Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma
Thorax,
October 1, 1999;
54(10):
894 - 899.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. PALMQVIST, T. IBSEN, A. MELLÉN, and J. LÖTVALL
Comparison of the Relative Efficacy of Formoterol and Salmeterol in Asthmatic Patients
Am. J. Respir. Crit. Care Med.,
July 1, 1999;
160(1):
244 - 249.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Miller-Larsson, H. Mattsson, E. Hjertberg, M. Dahlbäck, A. Tunek, and R. Brattsand
Reversible Fatty Acid Conjugation of Budesonide. Novel Mechanism for Prolonged Retention of Topically Applied Steroid in Airway Tissue
Drug Metab. Dispos.,
July 1, 1998;
26(7):
623 - 630.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1997 by the European Respiratory Society.
|